Autoantibody against 14-3-3 zeta: a serological marker in detection of gastric cancer.

Jiejie QinShuaibing WangPeng WangXiao WangHua YeChunhua SongLiping DaiKaijuan WangBinghua JiangJianying Zhang

Published in: Journal of cancer research and clinical oncology (2019)

Autoantibody against 14-3-3 zeta could be a potential diagnostic biomarker and improve the sensitivity of CEA, CA199 and CA724 in diagnosis of GC. Further largescale studies will be needed to validate its performance in GC patients after resection.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
gas chromatography
label free
sensitive detection